课题基金 / 基金详情

项目摘要

项目成果

JOHN Christopher KAPPES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Molecular Biology Core has been in operation for the past twelve years and has provided state-ofthe- art methodologies for numerous molecular biological techniques and recombinant protein expression and purification. The major goals of the Molecular Biology Core remain: 1. To collect and maintain suitable plasmid vectors and host for expression of HIV/SIV and related recombinant proteins 2. To provide a service for construction of recombinant plasmids and high level expression of HIV/SIV and related proteins, including HLA tetramers for immunological analysis. 3. To provide a service for purification of HIV/SIV and related proteins. 4. To establish an onsite repository for plasmids with HIV/SIV genes as well as recombinant HIV/SIV proteins. 5. To provide a service for construction of infectious HIVISIV proviral clones containing defined mutations in genes of interest. 6. To train personnel to assist in the various phases of plasmid construction and expression/purification of recombinant proteins for the purpose of facilitating technology transfer. The Molecular Biology Core has assisted, on average, over 25 CFAR members per year during the last funding period. The Core has averaged over $40,000 per year in chargebacks over the last funding period ($180,000 total). The Molecular Biology Core has provided critical reagents and expertise to UAB CFAR members that have funded individual R01 grants, UAB's National Corporative Vaccine Development Group and a multi-investigator funded program project to elucidate features of the HIV-1 reverse transcription. In the next funding period, the Core will expand its efforts to provide critical reagents for the international CFAR transmission and vaccine initiatives. Support of this facility is thus instrumental for the continued success of numerous investigators working in different areas of HIV pathogenesis, vaccine and therapeutic development currently conducted at UAB.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The effects of masculinizing gender-affirming hormone therapy for transgender men on susceptibility to HIV-1 infection modelled ex vivo in cervical mucosal tissue
  • 批准号:
    10748946
  • 项目类别:
  • 资助金额:
    $22.28万
  • 财政年份:
    2023
  • 负责人:
    JOHN Christopher KAPPES
  • 依托单位:
Elucidating mechanisms of HIV-1 mucosal transmission
  • 批准号:
    10553626
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    JOHN Christopher KAPPES
  • 依托单位:
Elucidating mechanisms of HIV-1 mucosal transmission
  • 批准号:
    10428455
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    JOHN Christopher KAPPES
  • 依托单位:
Elucidating mechanisms of HIV-1 mucosal transmission
  • 批准号:
    9892706
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    JOHN Christopher KAPPES
  • 依托单位:
国内基金
海外基金
Handbook of the Mathematics of the Arts and Sciences的中文翻译
  • 批准号:
    12226504
  • 项目类别:
    数学天元基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2022
  • 负责人:
    黄朝凌
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    35万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    82060278
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
促进肿瘤凋亡的融合蛋白CPP-TRAIL-ARTS C27的制备及机制研究
  • 批准号:
    81372444
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    易成
  • 依托单位: